Search Our Blog

 Subscribe to Our Blog!

Innovative Ideas for Global Patient Recruitment

Current Articles | RSS Feed RSS Feed

Watch Now: Patient Centricity Insights from The Michael J. Fox Foundation & The Diabetes Collective

  
  
  

If you're not putting your patients first, someone else will. Yesterday, BBK hosted a webinar on patient centricity in clinical research. The webinar, Patient-centric to the Core: Setting a New Standard for Engagement Strategies in Clinical Research, addresses the topic of how patient centricity is no longer a nice-to-have; it is a critical component of any study's success.

Bonnie A. Brescia to be Featured on Global Reach Broadcast with Té Revesz

  
  
  
GlobalReach

Founded in 1983 with a $30,000 loan and two military surplus desks, BBK Worldwide has become a global, multi-million dollar corporation that is changing the face of patient recruitment for clinical R&D in the pharma and biopharma industries. Today, our founding principals, Bonnie A. Brescia and Joan F. Bachenheimer have created a global enterprise – one that that is true to their philosophies of how a business, its products, services, and culture can create new opportunities for its staff, clients and benefit consumers.

The Michael J. Fox Foundation & The Diabetes Collective to Weigh in on Patient Centricity and Clinical Research

  
  
  
Fox Foundation resized 600

If you’re not putting your patients first, someone else will. Patient-centricity is no longer a nice-to-have; it is a critical component of any study’s success. Thoughtful and effective patient engagement and retention strategies should be employed throughout the entire clinical trial process – and the patient’s contribution to clinical research and the advancement of treatment options cannot be underestimated. Regardless of the inherent complexities of study management, clinical trial sponsors have an obligation to ensure patients have the best clinical trial experience possible. 

BBK Worldwide’s Mobile App Shortlisted for the 2014 SCRIP Awards

  
  
  
MyClinicalStudyBuddy MainPhoto

BBK Worldwide is pleased to announce its recognition as a finalist for its mobile app My Clinical Study Buddy in the “Best Technological Development in Clinical Trials” category in the 2014 SCRIP Awards. The annual SCRIP Awards acknowledge and applaud the pharmaceutical industry’s highest achievers across all parts of the value chain, and recognize both corporate and individual achievement. Award winners will be announced at a ceremony in London on December 3rd.

Re-investing in Patient Centricity: A Note from Founding Principal Bonnie A. Brescia

  
  
  
describe the image

What would you do if you had access to $3 million dollars to invest in improving the clinical research field? This might be a relatively small budget by some standards, but significant enough to make a difference and BBK has some very specific plans to do just that as we continue to deliver on our value proposition, BBK Worldwide: The Patients To Find the Cure

BBK Worldwide to Lead Sessions at Key September Events

  
  
  
describe the image

Embracing the hustle and bustle as summer comes to a close, BBK will be leading sessions at three key industry events beginning with Patient-Centered Clinical Trials 2014, to be held at the Hyatt Regency Hotel in Boston, September 4-5. Patient recruitment experts Bonnie A. Brescia, Matthew Stumm, and Aaron Fleishman will share insights on the benefits of employing an effective patient engagement strategy, and how a variety of tactics - from media to mobile apps - can be used to drive study participation and overall trial success.

Google X Searches for What it Means to be Healthy

  
  
  
describe the image

Prevention vs. Treatment
Google’s semi-secret and futuristic research lab, Google X, is busy working on something new – the Baseline Study. The idea is to define what it means to be “healthy” so that one day, this health baseline might help us better detect certain health risks and identify changes relating to serious, more debilitating diseases before they worsen. 

Led by renowned molecular biologist Andrew Conrad, in partnership with Duke and Stanford universities, the project will develop wearable technology to collect data and measurements from 175 people – a number that may increase to thousands of healthy participants with a duration of up to 10 years or longer. For example, participants may wear Google’s smart contact lenses to monitor glucose levels. Once the data is collected, Google will analyze the information and look for any patterns, also called “biomarkers,” to hopefully catalog and spot predictable patterns in diseases or irregularities.


BBK Worldwide Honored in Best Mobile App Category by Ragan Awards 2014

  
  
  
Mobile App

We are excited to announce our recent Honorable Mention for My Clinical Study BuddySM in the “Best Mobile App” category of the 2014 Ragan’s Health Care PR and Marketing Awards! Designed to integrate into study participants’ daily lives, My Clinical Study BuddySM is a key competitive differentiator in today’s increasingly shifting and ever-changing clinical landscape. Underscoring its adaptive model, the mobile app utilizes a technology-based solution that can change in real-time and adjust to sponsor’s needs in order to help reduce overall trial costs and maximize patient engagement.

Managing Social Media Chatter in Clinical Research: Shire Weighs In

  
  
  
describe the image

Utilizing social media in clinical research is a hot topic in the clinical R&D industry and many pharmaceutical companies are rightfully beginning to take note. According to a survey by the Pew Research Center, 85% of U.S. adults use the internet and 72% of those users say they have looked online for health information within the past year; however, The Tufts Center for the Study of Drug Development reports that only approximately 10% of trials reportedly use social media to recruit patients. Furthermore, BBK Worldwide research shows that pharmaceutical sponsors who use social media in their clinical trials are gaining a strong competitive advantage in terms of patient recruitment and retention.

BBK Worldwide Head of Social Strategy, Aaron Fleishman, Named to PharmaVOICE 100

  
  
  
aaron resized 600BBK is very proud to annouce that our very own Aaron Fleishman has been named to PharmaVOICE Magazine’s annual list of the 100 most inspiring people in life sciences! The award recognizes Aaron’s contributions in helping elevate patient volunteers in research so that their voices are heard.

As an industry leader, Aaron’s innovative strategies and efforts have resulted in the development of new educational and interactive resources to help improve the overall study participation experience while ensuring that patients and caregivers remain at the center of every campaign. “His passion for the industry and his patient-centric approach are an inspiration – for his colleagues, and our clients and partners,” said Joan F. Bachenheimer, BBK founding prinicipal.

All Posts